BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25759102)

  • 1. Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy.
    Franzese CJ; Bliden KP; Gesheff MG; Pandya S; Guyer KE; Singla A; Tantry US; Toth PP; Gurbel PA
    Am J Cardiol; 2015 May; 115(9):1204-11. PubMed ID: 25759102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
    Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
    Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
    Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of weight gain with coronary artery disease, inflammation and thrombogenicity.
    Chaudhary R; Bliden KP; Tantry US; Mohammed N; Mathew D; Gesheff MG; Franzese CJ; Gurbel PA
    J Thromb Thrombolysis; 2016 Apr; 41(3):394-403. PubMed ID: 26714821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients.
    Pirich C; Gaszo A; Granegger S; Sinzinger H
    Thromb Res; 1999 Nov; 96(3):219-27. PubMed ID: 10588465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary fish oil supplementation affects serum fatty acid concentrations in horses.
    O'Connor CI; Lawrence LM; Hayes SH
    J Anim Sci; 2007 Sep; 85(9):2183-9. PubMed ID: 17504965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with plasma omega-3 fatty acid levels in patients with suspected coronary artery disease.
    Chaudhary R; Saadin K; Bliden KP; Harris WS; Dinh B; Sharma T; Tantry US; Gurbel PA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():40-45. PubMed ID: 27720039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses.
    Leigh-Firbank EC; Minihane AM; Leake DS; Wright JW; Murphy MC; Griffin BA; Williams CM
    Br J Nutr; 2002 May; 87(5):435-45. PubMed ID: 12010583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease.
    Chaudhary R; Sukhi A; Chaudhary R; Jindal M; Vyas A; Rout A; Bliden K; Tantry U; Gurbel P
    J Thromb Thrombolysis; 2019 Oct; 48(3):373-381. PubMed ID: 31218482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy and inflammation in patients with diabetes treated with high dose aspirin.
    Chaudhary R; Bliden KP; Garg J; Mohammed N; Tantry U; Mathew D; Toth PP; Franzese C; Gesheff M; Pandya S; Gurbel P
    J Diabetes Complications; 2016; 30(7):1365-70. PubMed ID: 27237049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vein graft intimal thickening by eicosapentanoic acid: reduced thromboxane production without change in lipoprotein levels or low-density lipoprotein receptor density.
    Cahill PD; Sarris GE; Cooper AD; Wood PD; Kosek JC; Mitchell RS; Miller DC
    J Vasc Surg; 1988 Jan; 7(1):108-18. PubMed ID: 3336117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.
    Wheaton DH; Hoffman DR; Locke KG; Watkins RB; Birch DG
    Arch Ophthalmol; 2003 Sep; 121(9):1269-78. PubMed ID: 12963609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
    Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
    Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
    Bairati I; Roy L; Meyer F
    Can J Cardiol; 1992; 8(1):41-6. PubMed ID: 1617510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
    Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
    Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.
    Alusik S; Paluch Z; Lejsková M; Adámek T
    Int Angiol; 2010 Jun; 29(3):255-9. PubMed ID: 20502413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.